NCT07815587Not yet recruiting
Ultrasound Assessment of Gluteal Muscle in Patients Receiving Depot Antipsychotics and Healthy Volunteers
Ultrasound-Guided Assessment of Gluteal Muscle in Patients Receiving Depot Antipsychotics and Healthy Volunteers
Source: ClinicalTrials.gov · Last updated 11 Sept 2026
Brief summary (registry, in English)
This observational study will use ultrasound to assess the gluteal musculature in patients receiving depot antipsychotic medication and in healthy volunteers. The study aims to improve knowledge about anatomical conditions relevant to intramuscular depot injections.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 60 (estimated)
- First submitted
- 3 Sept 2026
- Start date
- 1 Sept 2026
- Primary completion date
- 31 Dec 2027
- Lead sponsor
- St. Olavs Hospital
- Diseases
- Schizophrenia
- NCT number
- NCT07815587
What you commit to
- Study type: Observational
- Planned participants: 60
- From 1 Sept 2026 to the primary completion date, 31 Dec 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous surgery that makes ultrasound examination difficult
Other illness
- Acute infections at the injection site
Who the study is looking for
- adults receiving depot antipsychotic medication and able to provide informed consent.
- Healthy volunteers: adults able to provide informed consent.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.